Hyperfine (HYPR) Projected to Announce Quarterly Earnings on Monday

Hyperfine (NASDAQ:HYPR) will likely be posting its Q3 2026 results after the market closes on Monday, November 9th. Analysts expect Hyperfine to post earnings of ($0.08) per share and revenue of $5.84 million for the quarter. Individuals may visit the company’s upcoming Q3 2026 earnings results page for the latest details on the call scheduled for Monday, November 9, 2026 at 4:30 PM ET.

Hyperfine (NASDAQ:HYPR) last announced its quarterly earnings results on Thursday, August 6th. The company reported ($0.09) earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of ($0.09). Hyperfine had a negative return on equity of 97.88% and a negative net margin of 210.75%. The company had revenue of $3.90 million during the quarter, compared to analyst estimates of $4.13 million.

Hyperfine Price Performance

NASDAQ HYPR opened at $0.73 on Monday. The company’s 50 day simple moving average is $0.81 and its 200 day simple moving average is $1.12. The firm has a market capitalization of $77.63 million, a PE ratio of -1.94 and a beta of 1.50. Hyperfine has a 12 month low of $0.70 and a 12 month high of $1.94. The company has a debt-to-equity ratio of 0.36, a current ratio of 6.15 and a quick ratio of 5.45.

Wall Street Analyst Weigh In

A number of equities research analysts have recently commented on the company. Loop Capital set a $2.00 price objective on Hyperfine in a research report on Tuesday, October 27th. BTIG Research reaffirmed a “buy” rating and set a $2.00 price objective on shares of Hyperfine in a research note on Tuesday, September 22nd. B. Riley Financial reiterated a “buy” rating and issued a $1.60 target price (down from $2.00) on shares of Hyperfine in a report on Monday, August 10th. Wall Street Zen downgraded shares of Hyperfine from a “hold” rating to a “sell” rating in a research report on Saturday. Finally, Lucid Cap Mkts started coverage on shares of Hyperfine in a research note on Tuesday, October 27th. They issued a “strong-buy” rating for the company. One analyst has rated the stock with a Strong Buy rating, three have given a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, Hyperfine has a consensus rating of “Moderate Buy” and a consensus price target of $2.02.

Hyperfine Company Profile

Hyperfine, Inc (NASDAQ: HYPR) is a medical technology company focused on making magnetic resonance imaging more accessible and convenient. The company develops portable, low-field MRI technology designed to bring brain imaging directly to patients in locations such as intensive care units, emergency departments, operating rooms and other point-of-care settings.

Hyperfine’s primary product is the Swoop Portable MR Imaging System, a compact MRI platform that can be moved to a patient’s bedside.